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Background: In recent years, several questionnaires have been developed for the assessment of foot health and its
impact on quality of life. In order for these tools to be useful outcome measures in clinical trials, their ability to
detect change over time (responsiveness) needs to be determined. Therefore, the aim of this study was to assess
the responsiveness of two commonly-used questionnaires in older people with foot pain.
Methods: Participants (n = 59; 24 women and 35 men, mean age [SD] 82.3 [7.8] years) allocated to the intervention
arm of a randomised controlled trial assessing the effectiveness of extra-depth footwear compared to usual care
completed the Foot Health Status Questionnaire (FHSQ) and Manchester Foot Pain and Disability Index (MFPDI) at
baseline and 16 weeks. Responsiveness of the FHSQ subscales (pain, function, footwear and general foot health)
and MFPDI subscales (pain, functional limitation and concern about appearance) was determined using (i) paired
t-tests, (ii) Cohen’s d, (iii) the standardised response mean (SRM), and (iv) the Guyatt index.
Results: Overall, the FHSQ pain subscale exhibited the highest responsiveness, as evidenced by a highly significant
paired t-test (p <0.001), Cohen’s d = 0.63 (medium effect size), SRM = 0.50 (medium effect size) and Guyatt index = 1.70
(huge effect size). The next most responsive measure was the FHSQ function subscale, as evidenced by a borderline
paired t-test (p = 0.050), Cohen’s d = 0.37 (small effect size), SRM = 0.26 (small effect size) and GI = 1.22 (very large
effect size). The FHSQ footwear, FHSQ general foot health and MFPDI pain, functional limitation and concern about
appearance subscales demonstrated lower responsiveness, with negligible to medium effect sizes.
Conclusion: The FHSQ pain and function subscales were most responsive to change in older people with foot pain
receiving a footwear intervention. These findings provide useful information to guide researchers in selecting
appropriate outcome measures for use in future clinical trials of foot disorders.
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Foot pain affects one in four people over the age of
45 years [1] and has a significant impact on mobility
[2,3] and quality of life [4,5]. In recent years, several
patient-reported outcome measures have been developed
to assess the severity and impact of foot pain in clinical
practice, epidemiological studies and clinical trials
[6-11]. In order to provide useful information, these
questionnaires need to be both valid (i.e. they actually* Correspondence: h.menz@latrobe.edu.au
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unless otherwise stated.measure what they are intended to measure) and repro-
ducible (i.e. they are able to produce the same scores in
identical conditions on different occasions). In addition,
to be useful outcome measures in clinical trials, such
tools need to be capable of detecting changes in health
status over time, a construct commonly referred to as
‘responsiveness’ [12-16].
Broadly speaking, there are two main approaches for
assessing the responsiveness of an outcome measure,
most commonly referred to as anchor-based and distri-
bution-based [17]. Anchor-based approaches compare
interval changes in outcome measure scores to a dichot-
omised ‘global’ rating of change score (using a questiontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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result of your treatment?”). The outcome measure score
that corresponds to a meaningful change (generally de-
fined as a response of “somewhat better” or above) is
considered to be the smallest difference which partici-
pants perceive as beneficial, and is termed the minimal
important difference, or MID [12]. The MID can then
be used as a benchmark for interpreting the effectiveness
of an intervention. Distribution-based approaches in-
volve examining the statistical distribution of change
scores for interval outcome measures (for either between-
group or within-group change over time comparisons),
and applying a range of statistics to calculate effect sizes
[18]. The smaller the MID or larger the effect size, the
more responsive an outcome measure is considered to be.
Recent reviews of measures of foot function, foot
health and foot pain indicate that few have undergone
adequate evaluation of responsiveness, thereby limiting
their use in clinical trials [6-11]. Two of the most com-
monly used and most extensively validated measures of
foot pain and disability are the Foot Health Status Ques-
tionnaire (FHSQ) [19] and the Manchester Foot Pain
and Disability Index (MFPDI) [20], but neither has
undergone detailed analysis of responsiveness. In a study
of people with plantar heel pain receiving foot orthoses,
the FHSQ was shown to be more responsive than the
Foot Function Index (FFI), based on the observation of
significant improvements in all four subscales of the
FHSQ but only two out of three subscales of the FFI
[21]. No responsiveness data have been published for the
English language version of the MFPDI, although a
modification of the MFPDI – the Manchester-Oxford
Foot Questionnaire – has been shown to be responsive
to improvements in foot health status following hallux
valgus surgery [22], and a recent study concluded that a
Dutch version of the MFPDI demonstrated only moder-
ate responsiveness [23].
Given the increasing use of the FHSQ and MFPDI in
foot and ankle research, there is a need for a more de-
tailed evaluation of responsiveness of these instruments
in order to determine whether it is appropriate to em-
ploy them as outcome measures in clinical trials of inter-
ventions for foot disorders. Therefore, as part of a
randomised controlled trial assessing the effectiveness of
extra-depth footwear in older people with foot pain
[24,25], we compared the responsiveness of the FHSQ




This study was undertaken as part of a larger rando-
mised controlled trial, the details of which have been
published previously [24,25]. Briefly, the trial was aparallel-group randomised controlled trial design with a
16-week follow-up period, with participants randomly
allocated to either a ‘usual care’ control group or the
intervention group. The intervention group was pro-
vided with off-the-shelf footwear at the baseline assess-
ment, and the data obtained from this group form the
basis of the current study.
Participants
Participants residing in Melbourne, Victoria, Australia
were recruited from the Department of Veterans’ Affairs
(DVA) database between October 2012 and May 2013.
To be eligible to be included in the study, veterans
needed to: (i) be aged 65 years or over; (ii) be a current
DVA Gold Card client not eligible for medical grade
footwear; (iii) have received podiatry treatment on at
least three occasions in the past five years; (iv) have dis-
abling foot pain, using the case definition of the MFPDI
[20] proposed by Roddy et al. [26]; (v) have persistent
foot pain, defined as foot pain present for at least
12 weeks, and; (vi) be capable of understanding the Eng-
lish language in verbal and written form. Participants
were deemed ineligible for inclusion if they: (i) were cur-
rently residing in a high level care residential aged care
facility; (ii) had diabetes and a history of foot ulceration
(or current foot ulceration) or diabetic peripheral neur-
opathy (diagnosed with the 5.07 Semmes-Weinstein
monofilament, using the International Working Group
on the Diabetic Foot protocol [27]); (iii) had a neurode-
generative disorder (e.g. Parkinson’s disease); (iv) had a
lower limb or partial foot amputation (although single toe
amputations will be permitted); (v) had been prescribed
contoured foot orthoses within the past 3 months; (vi)
were currently wearing the intervention footwear, or; (vii)
had cognitive impairment (defined as a score of <7 on the
Short Portable Mental Status Questionnaire [28]).
The Australian DVA Human Research Ethics Committee
provided ethical approval (approval number E012/005[5.1])
and the La Trobe University Human Ethics Committee for-
mally accepted this approval (E012/004). All participants
provided written informed consent prior to enrolment.
Intervention
The intervention group was provided with off-the-shelf,
extra-depth footwear (Dr Comfort®, Vasyli Medical,
Queensland, Australia). Men received the Brian style and
women received the Annie style. Both styles were available
in three width fittings (medium, wide, extra-wide) and fea-
tured a stretchable Lycra® upper with Velcro® closure and
a choice of two removable insoles (a flat, 4 mm foam in-
sole or a cushioning insole with a contoured heel cup,
7 mm thick under the forefoot and 15 mm thick under
the heel). The shoes were lightweight (ranging from ap-
proximately 200 to 500 gm, depending on size) and meet
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older people with foot problems [29-33]. The assessors
measured participants’ feet using a Brannock Device®
(Brannock Device Co, Inc., Liverpool, New York, USA) to
ensure appropriate length and width, using the fitting
protocol recommended by the footwear manufacturer
[34]. Intervention group participants who wore flat insoles
(or had been wearing contoured foot orthoses for more
than 3 months) in their current footwear were permitted
to wear them in their study footwear, provided that the fit
of the shoes was appropriate. The accuracy of the shoe fit-
ting procedure was evaluated by comparing total length,
forefoot width and forefoot girth measurements of the
foot obtained with a three-dimensional scanner to the cor-
responding last measurements of the allocated shoe size
provided by the manufacturer, and participants reported
the shoes to be well fitted and comfortable [35].Foot Health Status Questionnaire (FHSQ)
The FHSQ consists of 13 questions reflecting four
foot health-related domains: pain (4 questions), function
(4 questions), footwear (3 questions), and general foot
health (2 questions) [19]. Each question (item) is scored
on a 5-point Likert scale, and individual item scores are then
re-coded, tabulated, and finally transformed to a scale ran-
ging from 0 (indicating poorest foot health) to 100 (indicat-
ing best foot health) for each of the 4 domains. The FHSQ
demonstrates a high degree of content, criterion, and con-
struct validity and high retest reliability, and has been used
as an outcome measure in clinical trials for a range of foot
disorders [9]. The FHSQ was measured at baseline and at 4,
8, 12 and 16 weeks. For the purpose of the analysis in this
study, only the baseline and 16 week scores were used.Manchester Foot Pain and Disability Index (MFPDI)
The MFPDI (Isis Innovation Ltd., Oxford, UK) consists
of 19 statements prefaced by the phrase ‘Because of pain
in my feet’ , formalised under three subscales: functional
limitation (10 items), pain intensity (five items) and per-
sonal appearance (two items). The remaining two items
are concerned with difficulties in performing work or
leisure activities, which are omitted if the respondent is
of retirement age. Each of the 17 statements has a three-
category response: ‘none of the time’ (score = 0), ‘on
some days’ (score = 1) and ‘on most/every day(s)’ (score = 2)
[20]. The MFPDI has primarily been used in epidemiological
studies, but has also been employed as an outcome measure
in clinical trials [36,37]. The MFPDI was measured at base-
line and at 4, 8, 12 and 16 weeks. For the purpose of the
analysis in this study, only the baseline and 16 week scores
were used. To express the MFPDI as a linear, interval scale,
Rasch-transformed scores calculated from the original
MFPDI dataset by Gijon-Nogueron et al. [38] were used.Statistical analysis
All data were normally distributed based on observations
of linear normal Q-Q plots and skewness values of be-
tween −1 to +1. To evaluate the responsiveness of the
FHSQ and MFPDI subscales, four different effect size
statistics were applied [12-16]:
Paired t-test
The paired t-test was used to test the null hypothesis
that there was no change in the mean scores from base-








…where Dx = mean change scores between baseline and
follow-up, SD(Dx) = standard deviation in change scores
from baseline to 16 week follow-up, and n = sample size.
Cohen’s d
Also referred to as the standardised effect size, Cohen’s
d was calculated as the mean change scores between
baseline and 16 week follow-up, divided by the standard





The standardised response mean (SRM), also known as
the responsiveness treatment coefficient [40], was calcu-
lated as the mean change scores between baseline and
16 week follow-up divided by the standard deviation of






The Guyatt index (GI) [12] represents the magnitude
and variability in change scores for an outcome measure
relative to the minimal important difference of the





…where Δx = the minimal important difference of the
measure and MSEx = the standard deviation of the indi-
vidual change scores. In order to determine the minimal
important difference for each outcome measure sub-
scale, participants’ perceptions of the overall treatment
effect were documented at the 16 week follow-up using
Table 2 Mean (SD) scores for each outcome measure






Pain 54.8 (20.1) 67.4 (23.1)
Function 54.1 (22.8) 62.6 (27.9)
Footwear 30.5 (25.4) 28.2 (23.5)
General foot health 34.4 (24.4) 41.4 (26.4)
MFPDI
Pain 5.0 (1.6) 4.6 (2.1)
Functional limitation 10.5 (2.3) 9.4 (3.3)
Concern about appearance 1.1 (1.2) 1.0 (1.3)
FHSQ: Foot Health Status Questionnaire, MFPDI: Manchester Foot Pain and
Disability Index.
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since the start of the study?”, with a 5-point Likert scale
response (“marked worsening”, “moderate worsening”,
“same”, “moderate improvement” or “marked improve-
ment”). This scale was dichotomised, with a positive out-
come defined as moderate or marked improvement [24].
The minimal important difference for each measure was
then calculated as the mean change score in participants
who improved minus the mean change score in partici-
pants who did not improve or whose symptoms worsened.
To aid interpretation of the effect size statistics, the
following benchmarks were used: negligible effect size
(<0.15), small effect size (≥0.15 and <0.40), medium effect
size (≥0.40 and <0.75), large effect size (≥0.76 and <1.10),




Postal invitations were sent to 2,457 DVA clients and
341 were screened for eligibility by telephone. Of these,
121 underwent baseline screening and were randomised:
61 into the control group and 60 into the intervention
group. Of the 60 participants allocated to the interven-
tion group, one participant withdrew consent, leaving 59
participants with complete data. Characteristics of the
sample are provided in Table 1.
Responsiveness
Means and standard deviations for the FHSQ and
MFPDI subscales are shown in Table 2. The four respon-
siveness statistics for the FHSQ and MFPDI subscales
are shown in Table 3. Overall, the FHSQ pain subscaleTable 1 Participant characteristics (n = 59)
Age, mean (SD) years 82.3 (7.8)
Sex, n (%) female 24 (40.7)
Body mass index, mean (SD) kg/m2 29.2 (5.4)
Major medical conditions, n (%)
Diabetes 8 (13.6)
Heart disease 19 (32.2)
Osteoarthritis 48 (81.4)
Rheumatoid arthritis 3 (5.1)
Stroke 8 (13.6)
Use of >4 medications 50 (84.7)
Foot problems
Foot pain duration, mean (SD) years 13.1 (14.6)
Hallux valgus, n (%) 20 (33.9)
Lesser toe deformity, n (%) 52 (88.1)
Keratotic lesions on toes, n (%) 13 (22.0)
Plantar keratotic lesions, n (%) 37 (62.7)exhibited the highest responsiveness, as evidenced
by a highly significant paired t-test (p <0.001), Cohen’s
d = 0.63 (medium effect size), SRM = 0.50 (medium effect
size) and GI = 1.70 (huge effect size). The next most re-
sponsive measure was the FHSQ function subscale, as
evidenced by a borderline paired t-test (p = 0.050),
Cohen’s d = 0.37 (small effect size), SRM = 0.26 (small
effect size) and Guyatt index = 1.22 (very large effect size).
The FHSQ footwear, FHSQ general foot health and
MFPDI pain, functional limitation and concern about ap-
pearance subscales demonstrated lower responsiveness,
with negligible to medium effect sizes.
Discussion
The aim of this study was to evaluate the responsiveness
of two commonly used measures of foot pain and disabil-
ity: the Foot Health Status Questionnaire (FHSQ) [19] and
the Manchester Foot Pain and Disability Index (MFPDI)
[20]. To do this, we applied four of the most widely used
responsiveness statistics to FHSQ and MFPDI subscale
data obtained at baseline and at 16 weeks of follow-up
from a clinical trial of off-the-shelf footwear for reducing
foot pain in older people [24,25]. Overall, the FHSQ pain
subscale exhibited the highest responsiveness, as evi-
denced by a highly significant paired t-test and effect sizes
ranging from medium to huge. The next most responsive
measure was the FHSQ function subscale (borderline
paired t-test and effect sizes ranging from small to very
large). Based on these findings, it would appear that the
FHSQ is preferable to the MFPDI as an outcome measure
in clinical trials evaluating the effectiveness of interven-
tions in reducing foot pain and improving foot function in
older people.
The FHSQ footwear and MFPDI concern about ap-
pearance subscales performed poorly in this analysis,
with negligible to small effect sizes. However, these sub-
scales are not particularly useful in the context of a trial
Table 3 Responsiveness of the outcome measure subscales
Paired t-test Cohen’s d SRM GI
t p Value Interpretation Value Interpretation Value Interpretation
FHSQ
Pain −3.83 <0.001 0.63 Medium 0.50 Medium 1.70 Huge
Function −2.01 0.050 0.37 Small 0.26 Small 1.22 Very large
Footwear 0.89 0.378 0.09 Negligible 0.12 Negligible 0.21 Small
General foot health −2.06 0.044 0.29 Small 0.27 Small 0.68 Medium
MFPDI
Pain 1.61 0.114 0.26 Small 0.21 Small 0.51 Medium
Functional limitation 2.62 0.011 0.46 Medium 0.34 Small 0.41 Medium
Concern about appearance 0.61 0.542 0.09 Negligible 0.08 Negligible 0.06 Negligible
FHSQ: Foot Health Status Questionnaire, MFPDI: Manchester Foot Pain and Disability Index, SRM: standardised response mean, GI: Guyatt index.
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FHSQ footwear subscale items reflect difficulty with
obtaining suitable footwear, and the MFPDI concern
about appearance subscale items focus on participants’
self-consciousness regarding the appearance of their feet
and shoes. These two subscales were included in the
analysis for the sake of completeness, as the FHSQ and
MFPDI are generally administered in their entirety ra-
ther than as selected subscales. The poor responsiveness
reported here is therefore not a useful indicator of the
potential value of these subscales when applied to other
interventions. For example, Bennett et al. [42] have
demonstrated significant improvements in the FHSQ
footwear subscale following foot surgery, which is likely
due to the surgery allowing a wider range of shoes to be
worn postoperatively.
Our observation of the limited responsiveness of the
MFPDI is consistent with van der Zwaard et al. [23],
who reported that a Dutch translation of the MFPDI
was only moderately responsive to change in people
aged 50 years or over who were enrolled in a rando-
mised trial of treatment for forefoot pain. The authors
suggested several reasons for this, including: (i) the three
level response options (‘none of the time’ , on some days’
and ‘on most/every day/s’) are too widely spaced, (ii)
pain intensity is not directly addressed, and (iii) the concern
about appearance subscale (consisting of only two items)
has a large floor effect. In developing the Manchester-
Oxford Foot Questionnaire (a modification of the MFPDI
for use in foot surgery), Dawson et al. [43] addressed many
of these issues by increasing the response categories from
three to five, adding a pain severity item, and combining
the concern about appearance and ability to undertake so-
cial, recreational and work activities items into a separate
construct referred to as ‘social interaction’. The high re-
sponsiveness of this amended scale in patients undergoing
hallux valgus surgery [22] suggests that there may be some
scope for improving the MFPDI as an outcome measure.When interpreting these findings, it should be noted
that there is currently no accepted gold standard ap-
proach for assessing responsiveness of outcome mea-
sures, and that each statistical approach has limitations
(for a detailed discussion, see Husted et al. [13] and
Revicki et al. [16]). Paired t-tests provide an indication
of the statistical significance of the observed change in
the outcome measure scores, but this is influenced not
only by the magnitude of change, but also the sample
size (i.e. larger sample sizes are more likely to detect sta-
tistically significant differences). Cohen’s d and the stan-
dardised response mean are influenced by the variability
of the denominator (baseline scores for Cohen’s d and
change scores for standardised response mean), so higher
variability in the denominator will result in smaller effect
sizes. Finally, although the Guyatt index is considered by
some to be the most appropriate effect size statistic
[13,44], it requires the calculation of a minimal important
difference, which may vary across different populations,
conditions and interventions [16]. For this reason, we de-
termined the minimal important difference of the FHSQ
subscales by dichotomising a 5-point Likert scale response
of perceived overall improvement (i.e. a positive outcome
defined as moderate or marked improvement) and calcu-
lating mean change scores from our data, rather than
using minimal important difference scores calculated
from people with heel pain reported by Landorf et al.
[45]. As no minimally important difference scores have
been reported for the MFPDI, we used the same ap-
proach for each of the MFPDI subscales, which also
allowed us to make direct comparisons between the
two outcome measures. However, there is currently no
consensus regarding the most appropriate question or
number of response levels in determining the anchor
used to define the minimal important difference, and
anchor-based approaches have limited discriminative
ability in trials where most participants report improve-
ment in their condition [16].
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calculates the magnitude of the effect size in different
ways, the four statistics we used resulted in a reasonably
consistent pattern of responsiveness across the outcome
measure subscales. We can therefore be more confident
of the superiority of the FHSQ pain and function sub-
scales using this combined approach rather than using
one statistical test alone. Nevertheless, this approach
only addresses ‘internal’ responsiveness (the ability of a
measure to change over time), not ‘external’ responsive-
ness, which Husted et al. [13] have defined as the extent
to which changes in a measure over time relate to a cor-
responding change in an established reference measure
of health status. We were unable to evaluate external re-
sponsiveness in this study due to the absence of an ap-
propriate reference measure for comparison. Although
we collected Short Form 12 data from this sample, gen-
eric health outcome measures are generally less respon-
sive than condition-specific measures and are therefore
not considered to be suitable reference standards [6,22].
Outcome measures more directly related to mobility and
physical function in older people, such as the disability
index of the Health Assessment Questionnaire [46], may
be more appropriate reference standards for future
evaluation of external responsiveness.
Our findings provide further support for the continued
use of the FHSQ as an outcome measure in clinical trials
of foot disorders. However, although the recoding of FHSQ
response from a Likert scale to a 100-point scale enables
the FHSQ subscales to be expressed as interval data, the
FHSQ has so far not undergone Rasch analysis – a statis-
tical technique which evaluates whether overall scores
summed from ordinal items can be considered to be linear,
interval-level variables [47]. Such an analysis is necessary
to confirm whether it is indeed appropriate to analyse
FHSQ subscales using parametric statistical approaches.
In summary, this study has shown that the FHSQ pain
and function subscales are most responsive to change
over time in older people receiving a footwear interven-
tion to alleviate foot pain. The FHSQ footwear and gen-
eral foot health subscales and the three subscales of the
MFPDI exhibited lower responsiveness, so may not be
appropriate outcome measures in this population. Fur-
ther research is required to determine the internal re-
sponsiveness of the FHSQ as an outcome measure in
trials of other foot disorders, interventions and clinical
populations, and to evaluate external responsiveness
against an appropriate reference standard.
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